Skip to content

Study to evaluate the effect of Trivruttadi Leha Virechana in patients with Type-2 Diabetes Mellitus (Madhumeha)

Randomized Controlled Clinical Trial to Assess the Efficacy of Trivruttadi Virechan in the Management of Madhumeha with Special Reference to Type II Diabetes Mellitus. - NIc

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110762
Enrollment
60
Registered
2026-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Trivruttadi Leha Virechana: Dose: Dose of Trivruttadi Leha will be administered according to Koshta and Bala of patient until attainment of proper Virechana Lakshanas. Frequency: Singl

Sponsors

L K R Ayurvedic Mahavidyalay PG Training and Research Center Gadhinglaj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age Group 30 To 65 years old male/female Patient with BSL Patient with BSL Fasting 110 mg/dl Up To 180 and Post Prandial 180 mg/dl Up To 250 mg/dl. Patient NIDDM Type 2. Patient taken Metformin 500 mg once a daily.

Exclusion criteria

Exclusion criteria: Insulin dependent patient (Type-1 DM). Heart diseased patient. Diabetic patient suffering from complication like ketosis, T.B., AIDS, Malignancy, Hepatitis are rejected. History severe unstable angina, MI, CVA, Renal failure

Design outcomes

Primary

MeasureTime frame
1)Prabhuta Mutrata 2)Pipasa Adhikya 3)Kshudha Adhikya 4)Klama 5)Karapada Suptata 6)Karapada Daha 7)Pandiko Udveshtana 8)Mukha Shosha 9)Sandhi SholaTimepoint: at base line -after 4 weeks and after 8 weeks

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr. Dadasaheb Laxmna Mali

L K R Ayurvedic Mahavidyalay, P.G. Training and Research Center, Gadhinglaj.

drsachinayurved@gmail.com9823347244

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026